As summarized in Table 1, CDK1 expression showed no significant association with any clinicopathological parameters, including gender, age, tumor location, TNM stage, depth of invasion, lymph node status, or VALSG stage (all p > 0.05). Here, CDK1 is linked to neoplasm.